Funding

At the Costerton Biofilm Center we raised $11 million in competitive undiluted funding for the development of the drug target and proof-of-concept

 

Development 

  • First Stage Award from Incubator for Antibacterial Therapies in Europe.

Fundamental research

  • 6.62 mill DKK.

    High-potency solution against biofilms – expanding the global arsenal against antibiotic resistance

  • 1.5 mill DKK.

    A drug for biofilm dissolution and clearance

  • 0.25 mill DKK.

    Co-therapy of a novel P. aeruginosa biofilm disruptor with standard of care antibiotics

  • 3.5 mill DKK.

    Biofilm 2: A procedure to dismantle and eradicate bacterial biofilms

  • 5.3 mill DKK.

    DK openscreen

  • 3.9 mill DKK.

    Danish Council for Independent Research. Antimicrobials designed to dismantle antibiotic resistant biofilms

  • 10 mill DKK.

    Identification of antimicrobials that can dismantle biofilms

  • 5.3 mill DKK.

    Danish Council for Independent Research. Mechanisms involved in bacterial biofilm formation and antimicrobial tolerance

  • 2.8 mill DKK.

    Research collaboration. Development of biofilm controlling chemistry to prevent biofilm formation in paper manufacturing machines

  • 1.25 mill DKK.

  • 2.0 mill DKK.

    Biofilm 1: Identification of compounds that inhibit c-di-GMP synthesis in Pseudomonas aeruginosa

  • 3.7 mill DKK.

    Biofilms: a common course of Chronic infections

  • 29 mill DKK.

    Center for Antimicrobial Research

  • 2.5 mill DKK.

    Computer-based development of anti-pathogenic drugs